Bausch Health Companies (BHC) Other Non-Current Assets (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Other Non-Current Assets came in at $369.0 million in Q1 2026, down 2.89% year-on-year from $380.0 million in Q1 2025, and down 2.38% quarter-over-quarter from $378.0 million in Q4 2025.
Bausch Health Companies (BHC) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $369.0 million for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $369.0 million, down 2.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $369.0 million (down 2.89% YoY), and the FY2025 annual result was $378.0 million, up 4.13% from the prior year.
- Other Non-Current Assets came in at $369.0 million for Q1 2026 at Bausch Health Companies, down from $378.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $389.0 million in Q3 2024 to a low of $307.0 million in Q4 2023.
- The 5-year median for Other Non-Current Assets is $338.0 million (2022), against an average of $347.5 million.
- Across the five-year window, Other Non-Current Assets tumbled 45.87% in 2022 and advanced 21.79% in 2025, its largest moves.
- Bausch Health Companies' Other Non-Current Assets stood at $326.0 million in 2022, then fell by 5.83% to $307.0 million in 2023, then climbed by 18.24% to $363.0 million in 2024, then grew by 4.13% to $378.0 million in 2025, then slipped by 2.38% to $369.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $369.0 million (Q1 2026), $378.0 million (Q4 2025), and $382.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 47.63 Mn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | 369.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 369.00 Mn |
| Dec 31, 2025 | 378.00 Mn |
| Sep 30, 2025 | 382.00 Mn |
| Jun 30, 2025 | 388.00 Mn |
| Mar 31, 2025 | 380.00 Mn |
| Dec 31, 2024 | 363.00 Mn |
| Sep 30, 2024 | 389.00 Mn |
| Jun 30, 2024 | 329.00 Mn |
| Mar 31, 2024 | 312.00 Mn |
| Dec 31, 2023 | 307.00 Mn |
| Sep 30, 2023 | 328.00 Mn |
| Jun 30, 2023 | 325.00 Mn |
| Mar 31, 2023 | 318.00 Mn |
| Dec 31, 2022 | 326.00 Mn |
| Sep 30, 2022 | 341.00 Mn |
| Jun 30, 2022 | 338.00 Mn |
| Mar 31, 2022 | 334.00 Mn |
| Dec 31, 2021 | 340.00 Mn |
| Sep 30, 2021 | 343.00 Mn |
| Jun 30, 2021 | 596.00 Mn |